Statera Biopharma, Inc.: cashflow_financing
| Value | {"amount": 21519249, "concept": "us-gaap:NetCashProvidedByUsedInFinancingActivities", "currency": "USD"} |
|---|---|
| Period | 2012-01-01 – 2012-12-31 |
| Status | current |
| Entity | Statera Biopharma, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T12:34:08.365203+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/c31c1aef-4df7-4abb-b0ab-59099f03382b
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001171843-13-001049 · Open the official SEC filing →Retrieved: 2026-08-19T12:34:08.365203+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001318641/cashflow-financing/2012-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/c31c1aef-4df7-4abb-b0ab-59099f03382b
History
- no predecessors — first report